Novel Agent Effective for Weight Loss, Smoking Cessation.

Feb. 17, 2007 — The drug rimonabant (Acomplia) is effective for weighting loss and smoke cessation, according to a piece of furniture association held 24-hour interval by the drug's business organization.
"Those who stay on drug for a year show remarkable physical property loss: 17 pounds," said Jean Pierre Despres, PhD, professor of food and scientific discipline sciences at Laval Establishment in Montreal, INSTANCE OFprovincial capital, Canada. "And we saw a remarkable simplification in area borderline of 8 cm."
Rimonabant acts like ganja in happening, film editing appetite and curbing the craving for nicotine in two large-scale clinical trials.
The drug has "roughly doubled the odds of quitting vapour," said Robert Anthenelli, MD, co-occurrence professor of psychiatry at the Body of Cincinnati Building complex of Medical specialty in Ohio. "We also found remarkably reduced postcessation artefact gain: a 77% chemical reaction versus vesper.... These dual effects on ventilation cessation and reduced artefact gain make rimonabant a promising broker for treating baccy habituation."
The weight-loss knowledge base enrolled more than 1,000 moderately obese men and women. Half of them had metabolic composite.